Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Obsidian Therapeutics
Develops novel cell and gene therapies with pharmacologic operating systems.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
B2X
B2B
CEO
Paul Wotton
0
CIK Number
1,723,046
Legal Name
Obsidian Therapeutics, Inc.
Company Operating Status
Active
Country
United States
0
Crunchbase URL
crunchbase.com/organiz...apeutics
Date Incorporated
2015
Email Address
info@obsidiantx.ru
bd@obsidiantx.com
0
info@obsidiantx.com
0
Former CEO
Michael Gilman
Founded Date
2015
Founder
Steve Shamah
0
Michael Gilman
0
Tariq Kassum
0
Full Address
1030 Massachusetts Ave Cambridge, MA 02138
0
1 Patriots Park Bedford, 0173
Industry
Regenerative medicine
Immunotherapy
0
Cell therapy
Internal medicine
Stem cell
Tissue engineering
Biology
Medicine
Engineering
Therapeutics
•••
Investors
Samsara BioCapital
Amgen Ventures
0
Vertex Ventures
0
Takeda Ventures
0
Vertex Ventures HC
0
ShangPharma
0
The Column Group
0
Bristol-Myers Squibb
0
Vertex Pharmaceuticals
0
Atlas Venture
0
•••
Latest Funding Round Date
September 9, 2021
Latest Funding Round Amount (USD)
115,000,000
Latest Funding Type
Series B Round
Legal classification
Corporation
LinkedIn URL
@company/obsidian-therapeutics
Location
Cambridge, Massachusetts
0
United States
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
2
Phone Number
+17818066245
0
Pitchbook URL
pitchbook.com/profiles...162522-01
Total Funding Amount (USD)
164,500,000
Twitter URL
@Obsidian_Tx
Official Website
obsidiantx.com
Find more companies like Obsidian Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE